加载中
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
常规交易时段
US$6.07
−US$0.15 · -2.41%
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
52周区间
当前US$6.07
历史价格可能经过调整并有所延迟。
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
52周区间
当前US$6.07
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2203.4万 USD | 2566.3万 USD | 1385.4万 USD | 551.1万 USD | 596.6万 USD |
| 销货成本 | 1360.6万 USD | 1744.7万 USD | 940.1万 USD | 360.6万 USD | 306.3万 USD |
| 毛利 | 842.8万 USD | 821.6万 USD | 445.3万 USD | 190.5万 USD | 290.3万 USD |
| 研究与开发 | 324.9万 USD | 462.5万 USD | 414.8万 USD | 403.1万 USD | 293.9万 USD |
| 销售、一般及管理费用 | 2207万 USD | 2314.4万 USD | 2391.7万 USD | 1697.6万 USD | 1261.9万 USD |
| 营业费用 | 2531.9万 USD | 2776.9万 USD | 2806.5万 USD | 2100.7万 USD | 1555.8万 USD |
| 利息收入 | — | 64.3万 USD | 135.4万 USD | — | — |
| 利息支出 | 29.5万 USD | 12.8万 USD | 2万 USD | 2.2万 USD | 2.5万 USD |
| 折旧和摊销 | 33.3万 USD | 384.1万 USD | 184.7万 USD | 20.2万 USD | 26.6万 USD |
| 营业利润 | −1689.1万 USD | −1955.3万 USD | −2361.2万 USD | −1910.2万 USD | −1265.5万 USD |
| 净利润 | −1991.4万 USD | −2894.2万 USD | −2213.3万 USD | −1956.9万 USD | −1273.6万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$10.00
上涨空间 64.74%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2026年2月24日 | 1:12 | — | — |
股票拆分 | 2024年3月15日 | 1:7 | — | — |
股票拆分 | 2019年4月1日 | 1:25 | — | — |
已生效 2026年2月24日
1:12
已生效 2024年3月15日
1:7
已生效 2019年4月1日
1:25
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
